| Filed On | Filing |
|---|---|
| 20 Dec 2018 |
8-K: Completion of Acquisition or Disposition of Assets; Creation of a Direct Financial Obligation +6 more
SECTION 1. REGISTERED OFFICE – The address, including street, number, city, and county, of the registered office of Express Scripts Holding Company (the “Corporation”) in the State of Delaware is c/o the Corporation Trust Company, Corpor... |
| 19 Dec 2018 |
8-K: Regulation FD Disclosure
As previously announced, on March 8, 2018, Express Scripts Holding Company, a Delaware corporation (“Express Scripts”), entered into an Agreement and Plan of Merger (as amended, the “Merger Agreement”) with Cigna Corporation (“Cigna”), H... |
| 13 Dec 2018 |
8-K: Regulation FD Disclosure
As previously announced, on March 8, 2018, Express Scripts Holding Company, a Delaware corporation (“Express Scripts”), entered into an Agreement and Plan of Merger (as amended, the “Merger Agreement”) with Cigna Corporation (“Cigna”), H... |
| 21 Nov 2018 |
8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure
Attention: Marty Akins, Senior Vice President and General Counsel |
| 31 Oct 2018 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
ST. LOUIS, October 31, 2018 — Express Scripts Holding Company (Nasdaq: ESRX) announced consolidated 2018 third quarter net income of $1,071.6 million or $1.89 per diluted share. Consolidated 2018 third quarter adjusted earnings per dilut... |
| 18 Sep 2018 |
8-K: Other Events
BLOOMFIELD, Conn. & ST. LOUIS — (BUSINESS WIRE) — Cigna Corporation (NYSE: CI) (“Cigna”) and Express Scripts Holding Company (NASDAQ: ESRX) (“Express Scripts”) today announced that the Antitrust Division of the United States Department o... |
| 29 Aug 2018 |
8-K: Regulation FD Disclosure
Cigna Corporation (“Cigna”) disclosed that its officials expect to participate in meetings with investors and analysts over the next several weeks. During these meetings, Cigna officials expect to provide an update related to federal and... |
| 24 Aug 2018 |
8-K: Submission of Matters to a Vote of Security Holders; Other Events
ST. LOUIS, Aug. 24, 2018 /PRNewswire/ – Stockholders of Express Scripts Holding Company (NASDAQ: ESRX) today approved the proposed acquisition of Express Scripts by Cigna. |
| 13 Aug 2018 |
8-K: Other Events
Leading Independent Proxy Advisory Firm Glass Lewis Recommends Express Scripts Stockholders Vote “FOR” Merger Agreement with Cigna |
| 10 Aug 2018 |
8-K: Other Events
ST. LOUIS, Aug. 10, 2018 / PRNewswire / Express Scripts (NASDAQ: ESRX) today announced that Institutional Shareholder Services Inc. (“ISS”), a leading independent proxy advisory firm, has recommended that Express Scripts stockholders vot... |
| 09 Aug 2018 |
8-K: Regulation FD Disclosure
CIGNA REITERATES SUPPORT FOR PROPOSED MERGER WITH EXPRESS SCRIPTS August 2018 Exhibit 99.1 |
| 01 Aug 2018 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
ST. LOUIS, August 1, 2018 — Express Scripts Holding Company (Nasdaq: ESRX) announced consolidated 2018 second quarter net income of $877.3 million or $1.55 per diluted share. Consolidated 2018 second quarter adjusted earnings per diluted... |
| 02 Jul 2018 |
8-K: Entry into a Material Definitive Agreement
This Amendment No. 1 (this “Amendment”), dated as of June 27, 2018, to the Agreement and Plan of Merger (the “Merger Agreement”), dated as of March 8, 2018 (as amended, restated, modified or supplemented from time to time, the “Merger Ag... |
| 14 May 2018 |
8-K: Submission of Matters to a Vote of Security Holders
Express Scripts Holding Company (the “Company”) held its 2018 annual meeting of stockholders (the “Annual Meeting”) at the Company’s principal executive offices on Thursday, May 10, 2018. Of the 561,531,099 shares outstanding and entitle... |
| 02 May 2018 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
ST. LOUIS, May 2, 2018 — Express Scripts Holding Company (Nasdaq: ESRX) announced consolidated 2018 first quarter net income of $623.2 million or $1.10 per diluted share. Consolidated 2018 first quarter adjusted earnings per diluted shar... |
| 25 Apr 2018 |
8-K: Regulation FD Disclosure
FORWARD LOOKING STATEMENTS Information included or incorporated by reference in this communication, and information which may be contained in other filings with the Securities and Exchange Commission (the “SEC”) and press releases or oth... |
| 24 Apr 2018 |
8-K: Other Events
As previously announced, on March 8, 2018, Cigna Corporation (“Cigna”), Express Scripts Holding Company (“Express Scripts”) and certain of Cigna’s affiliates entered into a definitive agreement whereby Cigna will acquire Express Scripts.... |
| 09 Mar 2018 |
8-K: Entry into a Material Definitive Agreement; Amendments to Articles/Bylaws; Change in Fiscal Year
This AGREEMENT AND PLAN OF MERGER, dated as of March 8, 2018 (this “Agreement”), is by and among CIGNA CORPORATION, a Delaware corporation (“Parent”), EXPRESS SCRIPTS HOLDING COMPANY, a Delaware corporation (the “Company”), HALFMOON PARE... |
| 08 Mar 2018 |
8-K: Other Events
Drives greater affordability and connectivity with customers and their health care providers, while making health care simpler |
| 27 Feb 2018 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
ST. LOUIS, February 27, 2018 — Express Scripts Holding Company (Nasdaq: ESRX) announced consolidated 2017 fourth quarter and full year net income of $2,327.6 million and $4,517.4 million, respectively, or $4.10 and $7.74 per diluted shar... |
Loading...